{"id":140297,"date":"2024-12-06T14:43:55","date_gmt":"2024-12-06T09:13:55","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=140297"},"modified":"2024-12-06T14:43:58","modified_gmt":"2024-12-06T09:13:58","slug":"pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/","title":{"rendered":"Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3733237674\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1179053440\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>With a market capitalization of Rs 447.73 crore, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/VENUSREM\" target=\"_blank\" rel=\"noreferrer noopener\">Venus Remedies Limited<\/a><\/strong> were trading at Rs 334.95 per share, increasing around 4.25 percent as compared to the previous closing price of Rs 323.15 apiece.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Reason for rise:-&nbsp;<\/strong><\/h2><p>The company shares have seen positive movement after Venus Remedies Limited announced the approval of Pemetrexed 500mg, a chemotherapeutic drug often used in the treatment of lung cancer and rnesothelioma, in the Philippines. This permission is a significant step forward in the company&#8217;s efforts to increase its footprint in the fast-growing Southeast Asian pharmaceutical sector.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financial Performance:-&nbsp;<\/strong><\/h2><p>Looking forward to the company&#8217;s financial performance, revenue dipped slightly from Rs 167.72 crore in Q2FY24 to Rs 167.45 crore in Q2Y25. During the same period, net profit plummeted by 68 percent, from Rs 9.94 crore to Rs 3.51 crore.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-4161728557\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Market expansion:-&nbsp;<\/strong><\/h2><p>Venus Remedies plans to increase its presence in government institutions across India, capitalizing on the demand for antimicrobial products. Additionally, the company aims to expand its global reach, targeting a presence in 100 countries by 2025.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>New Development:-&nbsp;<\/strong><\/h2><p>Venus Remedies focuses on developing innovative therapies targeting Antimicrobial Resistance (AMR) due to its global health impact. Additionally, the company plans to enter the consumer healthcare market, launching disruptive products in pain management, gastroenterology, and vitamins over the next five years.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Ratio analysis:-&nbsp;<\/strong><\/h2><p>The company\u2019s critical ratios show that the return on equity increased from 5.77 percent in FY22-23 to 5.84 percent in FY23-24, while the return on capital employed increased from 7.37 percent to 8.17 percent. The net profit margin (NPM) for fiscal year 23-24 is 4.73 percent.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Shareholding pattern:-&nbsp;<\/strong><\/h2><p>In the company\u2019s recent shareholding pattern, the Promoters of the company own 41.76 percent while Retail shareholders own a 57.06 percent stake in the company and domestic Institutional Investors own a 1.18 percent stake.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Company Profile:-&nbsp;<\/strong><\/h2><p>VSR is a leading manufacturer of meropenem antibiotics and an emerging player in AMR drugs in India. The company provides a diverse range of pharmaceutical products for various therapeutic areas, including anti-infectives, antimicrobial resistance, oncology, neurology, pain management, skin and wound care.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by:- Abhishek Singh&nbsp;<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-4026817206\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-3114535335\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.&nbsp; With a market capitalization of Rs 447.73 crore, the shares of Venus Remedies Limited were trading at Rs 334.95 per share, increasing around 4.25 percent as compared to the previous closing price [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[6616,948,936,2597,19485,9806,25201,9805,9807],"class_list":["post-140297","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch","tag-venus-remedies","tag-venus-remedies-latest-news","tag-venus-remedies-news","tag-venus-remedies-share-price","tag-why-is-venus-remedies-going-up"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines\" \/>\n<meta property=\"og:description\" content=\"The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-06T09:13:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-06T09:13:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/\",\"name\":\"Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-12-06T09:13:55+00:00\",\"dateModified\":\"2024-12-06T09:13:58+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines - Trade Brains Features","description":"The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines","og_description":"The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-06T09:13:55+00:00","article_modified_time":"2024-12-06T09:13:58+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/","name":"Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-12-06T09:13:55+00:00","dateModified":"2024-12-06T09:13:58+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of the pharmaceutical company gained up to 8 percent after the company received Marketing Authorization for Pemetrexed 500mg in the Philippines.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-7-after-company-to-sell-its-lung-cancer-drug-in-philippines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 7% after company to sell its lung cancer drug in Philippines"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=140297"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140297\/revisions"}],"predecessor-version":[{"id":140306,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140297\/revisions\/140306"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=140297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=140297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=140297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}